American Well Corp

Overview

Compare with Sezzle, PFSweb or Radware, or pick any stock.

• TickerAMWL on NYSE¹
• IndustryServices-Business Services, NEC¹
• HeadquartersBoston, Massachusetts¹
• Incorporated inDE³
• Business address75 State Street, 26Th Floor, Boston, Ma 02109³
• Filer categoryAccelerated filer, Smaller reporting company³

See how the biggest companies compare on our leaderboards

Amwell is a leading enterprise platform and software company digitally enabling hybrid care. We empower health providers, payers, and innovators to achieve their digital ambitions, enabling a coordinated experience across in-person, virtual and automated care. We provide our clients with the core technology and services necessary to successfully develop and distribute digital care programs that meet their strategic, operational, financial and clinical objectives under their own brands.⁵ From its latest annual report

Corporate structure

American Well Corp sits at the top of its group. 11 entities, 6 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What American Well Corp reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

Investments

Intangibles and goodwill

Inventory

Properties, in its own words

Our principal executive office is located in Boston, Massachusetts and is a LEED certified building. We also have offices in Ramat Gan, Israel, Tysons Corner, Virginia, Dublin, Ireland and Bogotá and Medellin, Colombia. All of our office locations are leased. We also maintain hardware inventory in facilities based in San Diego, California.

We have instituted a remote work policy which has allowed us to reduce our office footprint, including approximately 50% of our corporate headquarters footprint, reducing the climate impact associated with our team members’ commuting. We believe that our facilities are adequate to meet our needs for the immediate future, and that, should it be needed, suitable additional space will be available to accommodate any such expansion.

Item 2 of the 10-K filed Feb 12, 2026.⁵

Leadership

Who has led American Well Corp, and when. Pick a name to see everywhere that person has worked.

• Chief executive officerIdo Schoenberg Sep 16, 2020 to now¹⁵
• Chief executive officerRoy Schoenberg Sep 16, 2020 to Sep 22, 2023¹⁶
• ChairIdo Schoenberg Sep 16, 2020 to now¹⁵
• PresidentPhyllis Gotlib Sep 16, 2020 to now¹⁷
• PresidentRoy Schoenberg Sep 16, 2020 to Sep 22, 2023¹⁶
• Chief financial officerMark Hirschhorn Oct 29, 2024 to now¹⁸
• Chief financial officerRobert Shepardson Nov 3, 2021 to Oct 3, 2024¹⁹
• Chief operating officerKurt Knight Sep 16, 2020 to Dec 4, 2024²⁰

Subsidiaries and ownership

Subsidiaries (Exhibit 21)

• AMWELL Colombia SAS Colombia⁴
• American Well Corporation Ireland Limited Ireland⁴
• American Well Corporation UK Limited England⁴
• American Well Israel Ltd Israel⁴
• Amwell Telehealth, LLC Delaware⁴
• Avizia LLC Delaware⁴
• Conversa Health, LLC Delaware⁴
• National Telehealth Network, LLC Delaware⁴
• SilverCloud Health Australia Pty LTD Australia⁴
• SilverCloud Health Inc. Delaware⁴
• SilverCloud Health, LLC Delaware⁴

The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.

Timeline

1. Aug 4, 20268-K Results of operations⁴⁰
2. Jul 21, 20268-K Change of auditor⁴¹
3. Jul 14, 20268-K Executive or director change⁴²
4. Jun 22, 20268-K Shareholder vote⁴³
5. May 12, 20268-K Executive or director change⁴⁴
6. May 5, 20268-K Results of operations⁴⁵
7. Apr 2, 20268-K Executive or director change⁴⁶
8. Feb 12, 20268-K Results of operations⁴⁷
9. Jan 8, 20268-K Entered a material agreement⁴⁸
10. Jan 2, 20268-K Entered a material agreement⁴⁹
11. Nov 4, 20258-K Results of operations⁵⁰
12. Aug 5, 20258-K Results of operations⁵¹
13. Sep 16, 2020New chief executive Roy Schoenberg becomes CEO¹⁶
14. Sep 16, 2020New chief executive Ido Schoenberg becomes CEO¹⁵

Calendar

Coming up

1. Nov 3, 2026Reports results for the quarter ending Sep/2026 A year earlier it reported ($1.74) a share, on Nov 4, 2025.⁵²

When it reported results

1. Aug 4, 2026Reported quarterly or annual results⁴⁰
2. May 5, 2026Reported quarterly or annual results⁴⁵
3. Feb 12, 2026Reported quarterly or annual results⁴⁷
4. Nov 4, 2025Reported quarterly or annual results⁵⁰
5. Aug 5, 2025Reported quarterly or annual results⁵¹
6. May 1, 2025Reported quarterly or annual results⁵³
7. Feb 12, 2025Reported quarterly or annual results⁵⁴
8. Oct 30, 2024Reported quarterly or annual results⁵⁵

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

606 filings to the SEC since October 2021: 6 annual reports, 15 quarterly reports, 51 major events, 358 insider forms, 30 large holders, 146 other. The latest 20:

1. Oct 5, 20264 EDGAR
2. Oct 5, 20264 EDGAR
3. Oct 5, 20264 EDGAR
4. Oct 5, 20264 EDGAR
5. Oct 1, 2026144 EDGAR
6. Oct 1, 2026144 EDGAR
7. Oct 1, 2026144 EDGAR
8. Sep 3, 20264 EDGAR
9. Sep 3, 20264 EDGAR
10. Sep 3, 20264 EDGAR
11. Sep 1, 2026144 EDGAR
12. Sep 1, 2026144 EDGAR
13. Aug 13, 2026SCHEDULE 13G/A EDGAR
14. Aug 4, 202610-Q EDGAR
15. Aug 4, 20268-K EDGAR
16. Jul 21, 20268-K EDGAR
17. Jul 14, 20268-K EDGAR
18. Jul 1, 20264 EDGAR
19. Jul 1, 20264 EDGAR
20. Jul 1, 20264 EDGAR

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

288 open-market trades by officers, directors and large owners since October 2021: 1 buys and 287 sales. Grants, option exercises and gifts are left out.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

• Senvest Management, LLCSCHEDULE 13G/A, 6 filings Oct 14, 2022 to Aug 13, 2026⁵⁶
• Morgan StanleySCHEDULE 13G/A, 2 filings Nov 6, 2024 to May 11, 2026⁵⁷
• Ido SchoenbergSCHEDULE 13G/A, 5 filings Feb 14, 2022 to Feb 13, 2026⁵⁸
• Funicular Funds, LPSCHEDULE 13G, 1 filing Jan 26, 2026⁵⁹
• Caledonia (Private) Investments Pty LtdSCHEDULE 13G/A, 5 filings Feb 15, 2022 to Nov 14, 2025⁶⁰
• VANGUARD GROUP INCSC 13G/A, 6 filings Feb 9, 2022 to Nov 12, 2024⁶¹
• Allianz SESC 13G/A, 1 filing Feb 9, 2022⁶²

Executive pay

What the company paid its top executives, from the summary compensation table in its proxy statement. Total pay includes salary, bonus, stock and option awards and other pay, as the company valued them.

SEC filer profile

How American Well Corp is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

• Name on EDGARAmerican Well Corp¹
• CIK0001393584
• Employer ID (EIN)20-5009396⁵
• Filer statusAccelerated filer not an emerging growth company; a smaller reporting company; not a shell company⁵
• Incorporated inDelaware⁵
• Fiscal year endsDecember 31¹
• Industry code (SIC)7389 Services-Business Services, NEC¹
• SEC reviewing officeOffice of Trade & Services, Division of Corporation Finance¹
• Business address75 State Street, 26Th Floor, Boston, MA 02109¹
• Phone617-205-3500¹
• Shares outstanding14,904,513 Common Class A shares; 1,369,518 Common Class B shares; 277,777 Common Class C shares as of Jan 30, 2026⁵
• Public float$125.0M as of Jun 30, 2025⁵
• AuditorPricewaterhouseCoopers LLP, Boston, Massachusetts, United States PCAOB ID 238; it also attests to the company’s internal control over financial reporting⁵
• On EDGAR sinceMar 14, 2007¹
• Filings798 in all: 4 (437), 144 (120), 8-K (64), 3 (30), 10-Q (18), SC 13G/A (15), D (10), 4/A (9)¹
  All 36 form types

  SC 13G (9), DEFA14A (8), SCHEDULE 13G/A (8), CORRESP (7), S-8 (7), 10-K (6), DEF 14A (6), 5 (5), ARS (4), UPLOAD (4), 424B7 (3), DRSLTR (3), 424B4 (2), D/A (2), DRS (2), DRS/A (2), EFFECT (2), REGDEX (2), S-1 (2), S-1/A (2), SEC STAFF LETTER (2), 10-K/A (1), 8-A12B (1), CERT (1), PRE 14A (1), S-1MEF (1), S-3ASR (1), SCHEDULE 13G (1)

• Latest filingsAnnual report (10-K) Feb 12, 2026
  Quarterly report (10-Q) Aug 4, 2026
  Proxy statement (DEF 14A) Apr 23, 2026
  Latest 8-K (8-K) Aug 4, 2026

Securities registered for trading

From the cover page of the 10-K filed Feb 12, 2026 (Section 12(b) of the Exchange Act).⁵

Risk factors and legal proceedings

The risks American Well Corp names in Item 1A of its 10-K filed Feb 12, 2026: 62 risks under these headings, as written.⁵

• The risks and uncertainties described below are not the only ones we face. Additional risks and uncertainties that we are unaware of or that we do not currently deem material may also become important factors that adversely affect our business. If any of the events contemplated by the following discussion of risks should occur, our business, financial condition, results of operations and cash flows could suffer significantly. The following is a summary of all the material risks known to us.
• Risks Related to Our Financial Position
• We have a history of losses, which we expect to continue, and we may never achieve or sustain profitability.
• A significant portion of our revenue comes from a limited number of clients and we may be unable to retain our key clients.
• We may need additional capital to support the growth of our business, which may not be available to us on acceptable terms or at all.
• We have incurred and may in the future incur non-cash impairment charges.
• Risks Related to Our Business and Industry
• The digital care market is still developing and volatile and may develop slower than we expect and be subject to negative publicity.
• Rapid technological change in our industry presents us with significant risks and challenges.
• We operate in a competitive industry and may not able to compete effectively.
• Healthcare reform legislation and other changes in the healthcare industry and in healthcare spending could adversely affect our business, financial condition and results of operations.
• If growth in the number of individuals covered by our health systems and health plans decreases, or the number of products or services that we are able to sell to our clients decreases due to legal, economic or business developments, our revenue will likely decrease.

Legal proceedings

From time to time, we may become involved in legal proceedings arising in the ordinary course of our business. We are not presently a party to any legal proceedings that, in the opinion of our management, would individually or taken together have a material adverse effect on our business, financial condition, results of operations or cash flows. Regardless of outcome, litigation can have an adverse impact on us due to defense and settlement costs, diversion of management resources, negative publicity, reputational harm and other factors.

The opening of Item 3, Legal Proceedings.⁵